TRCT
EVGN icon

Tower Research Capital (TRC)’s Evogene EVGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-290
Closed -$890 – 5770
2024
Q3 		$890 Buy
+290
New +$1.25K ﹤0.01% 5239
2022
Q2 		– Sell
-454
Closed -$6K – 6183
2022
Q1 		$6K Sell
454
-367
-45% -$4.95K ﹤0.01% 4871
2021
Q4 		$13K Buy
+821
New +$18.6K ﹤0.01% 4169
2021
Q3 		– Sell
-91
Closed -$3K – 5861
2021
Q2 		$3K Buy
+91
New +$3.56K ﹤0.01% 4909
2021
Q1 		– Sell
-114
Closed -$5K – 5471
2020
Q4 		$5K Buy
114
+49
+75% +$1.73K ﹤0.01% 4613
2020
Q3 		$3K Buy
+65
New +$1.16K ﹤0.01% 4492
2017
Q2 		– Sell
-10
Closed -$1K – 2909
2017
Q1 		$1K Buy
+10
New +$521 ﹤0.01% 2784
2016
Q4 		– Sell
-8
Closed -$1K – 3963
2016
Q3 		$1K Sell
8
-75
-90% -$4.93K ﹤0.01% 3285
2016
Q2 		$5K Sell
83
-38
-31% -$2.65K ﹤0.01% 3368
2016
Q1 		$8K Sell
121
-1
-0.8% -$69 ﹤0.01% 2185
2015
Q4 		$10K Buy
122
+112
+1,120% +$8.32K ﹤0.01% 2103
2015
Q3 		$1K Sell
10
-5
-33% -$435 ﹤0.01% 3595
2015
Q2 		$1K Sell
15
-51
-77% -$4.94K ﹤0.01% 3981
2015
Q1 		$6K Buy
66
+6
+10% +$559 ﹤0.01% 3137
2014
Q4 		$6K Sell
60
-10
-14% -$1.06K ﹤0.01% 2580
2014
Q3 		$9K Buy
+70
New +$9.66K ﹤0.01% 2886
2014
Q1 		– Sell
-30
Closed -$6K – 4579
2013
Q4 		$6K Buy
+30
New +$5.54K ﹤0.01% 3394

Other funds holding EVGN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Tower Research Capital (TRC)'s EVGN Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Evogene (EVGN) in Q4 2024, closing a stake of 290 shares — an estimated $890 sold.

Tower Research Capital (TRC) first reported a position in EVGN in Q4 2013 and held it in 17 quarters. The position peaked at $13K in Q4 2021. 15 funds tracked by Wall St. Rank hold EVGN as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining Evogene position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 290 Evogene shares in Q4 2024, an estimated $890.
  • Tower Research Capital (TRC) first reported a position in Evogene in Q4 2013 and held it in 17 quarters.
  • Tower Research Capital (TRC)'s Evogene position peaked at $13K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.